Eastman Kodak Company (KODK)
:KODK
Advertisement

Kodak (KODK) AI Stock Analysis

Compare
1,372 Followers

Top Page

KODK

Kodak

(NYSE:KODK)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 4o)
Rating:49Neutral
Price Target:
$8.00
▲(26.78% Upside)
Kodak's overall stock score is primarily impacted by its weak financial performance and concerning valuation metrics. While technical analysis suggests some potential for upward momentum, the lack of profitability and cash flow challenges present significant risks. Strategic initiatives in the AMC segment and U.S. manufacturing offer some hope, but financial stability remains a critical concern.

Kodak (KODK) vs. SPDR S&P 500 ETF (SPY)

Kodak Business Overview & Revenue Model

Company DescriptionKodak (KODK) is a global technology company that primarily focuses on imaging and printing solutions. Originally known for its photographic film products, Kodak has evolved its business model to emphasize digital imaging, commercial printing, and advanced materials and chemicals. The company operates through several segments, including Digital Printing, Traditional Printing, and Advanced Materials and Chemicals, offering products such as digital cameras, printing systems, and innovative materials for various industries.
How the Company Makes MoneyKodak generates revenue through multiple key streams. The Digital Printing segment contributes significantly by providing commercial printing solutions, including inkjet technology and workflow software, catering to businesses in need of high-quality printing services. The Traditional Printing segment, which includes film and paper products, still contributes to revenue but has seen a decline due to the shift toward digital solutions. Additionally, Kodak's Advanced Materials and Chemicals segment offers specialized materials used in various applications, including electronics and 3D printing, further diversifying its income. The company has formed strategic partnerships with other technology firms and service providers to enhance its product offerings and market reach, allowing it to leverage synergies and increase its revenue potential.

Kodak Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down revenue across different regions, revealing where Kodak is strongest and where it may face risk or growth potential due to local economic conditions or market share shifts.
Chart InsightsKodak's revenue trends reveal a mixed regional performance. The U.S. remains a key market, showing resilience despite recent fluctuations. However, EMEA and APAC regions are experiencing notable declines, possibly due to macroeconomic pressures. The earnings call highlights growth in the Advanced Materials and Chemicals segment, yet overall financial metrics are under pressure, with concerns about Kodak's long-term viability. Strategic investments in U.S. manufacturing and pharmaceutical initiatives offer potential growth avenues, but the company's ability to navigate financial challenges remains critical.
Data provided by:Main Street Data

Kodak Earnings Call Summary

Earnings Call Date:Aug 11, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Mar 17, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture for Kodak. While there were positive developments, such as growth in the AMC business and progress in pharmaceutical manufacturing, financial metrics like revenue, gross profit, and net income showed declines. Additionally, concerns about the company's ability to continue as a going concern added a negative aspect to the sentiment.
Q2-2025 Updates
Positive Updates
Advanced Materials and Chemicals (AMC) Growth
The AMC business showed continued revenue growth, demonstrating successful investments in this area.
U.S. Manufacturing Commitment
Kodak reinforced its commitment to U.S. manufacturing, with several products like motion picture film, digital printers, ink, and chemicals made domestically.
Pharmaceutical Manufacturing Initiative
Kodak's cGMP pharmaceutical manufacturing facility is now FDA registered and certified to manufacture and sell regulated pharmaceutical products.
Series C Preferred Stock Exchange
The Series C preferred stock was exchanged for common stock, eliminating $100 million in preferred stock and over $24 million in accrued dividends.
Pension Plan Termination Process
The KRIP termination is proceeding as planned, with an estimated $500 million to revert to the company, aiding in debt reduction.
Negative Updates
Revenue Decline
Revenue for Q2 2025 was $263 million, a slight decline from $267 million in Q2 2024, reflecting a 1% decrease year-over-year.
Gross Profit Decline
Gross profit percentage decreased from 22% in Q2 2024 to 19% in Q2 2025, impacted by lower volumes and higher costs.
Net Loss for the Quarter
Kodak reported a net loss of $26 million for Q2 2025 compared to a net income of $26 million in the prior year quarter.
Operational EBITDA Decline
Operational EBITDA for Q2 2025 was $9 million, down from $12 million in the prior year quarter, impacted by lower volumes and costs.
Going Concern Doubts
There is substantial doubt about Kodak's ability to continue as a going concern due to upcoming maturities of debt and preferred stock.
Company Guidance
During the Eastman Kodak Q2 2025 Earnings Conference Call, guidance focused on several key metrics and initiatives. Kodak reported a revenue of $263 million for the second quarter of 2025, compared to $267 million in the same period in 2024, marking a slight decline. The company's gross profit percentage stood at 19%, down from 22% in the previous year, attributed to lower volumes and increased manufacturing costs. A significant focus was on deleveraging, with plans to use approximately $500 million in reverted pension assets to reduce long-term debt. Operational EBITDA decreased to $9 million from $12 million year-over-year, impacted by higher aluminum costs and lower volumes. The company highlighted growth in its Advanced Materials and Chemicals (AMC) segment, with a newly registered cGMP pharmaceutical manufacturing facility in Rochester, New York. Additionally, Kodak discussed the conversion of Series C preferred stock to common stock, representing about 15.7% of outstanding shares post-exchange. Despite challenges, Kodak emphasized its commitment to U.S. manufacturing and its strategic investments in innovation and operational efficiency.

Kodak Financial Statement Overview

Summary
Kodak's financial performance is challenged by low margins and negative cash flow trends. While there is some revenue growth and a balanced debt-to-equity ratio, the overall financial health is hindered by operational inefficiencies and cash flow issues.
Income Statement
Kodak's income statement shows mixed results. The TTM Gross Profit Margin is 20.67%, indicating moderate efficiency in production. However, the Net Profit Margin is low at 0.57%, reflecting challenges in converting revenue into profit. Revenue growth is positive at 0.77% TTM, but historical fluctuations suggest instability. The EBIT margin is negative, highlighting operational inefficiencies, while the EBITDA margin is slightly better at 7.94% TTM.
Balance Sheet
The balance sheet reveals a moderate financial position. The Debt-to-Equity Ratio is 0.65 TTM, indicating a balanced approach to leveraging. Return on Equity is low at 0.76% TTM, suggesting limited profitability from equity. The Equity Ratio stands at 41.49% TTM, showing a reasonable level of equity financing.
Cash Flow
Kodak's cash flow statement presents significant challenges. The Free Cash Flow Growth Rate is negative, indicating declining free cash flow. The Operating Cash Flow to Net Income Ratio is negative, reflecting cash flow issues. However, the Free Cash Flow to Net Income Ratio is high at 4.4 TTM, suggesting some ability to generate cash relative to net income.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.04B1.04B1.12B1.21B1.15B1.03B
Gross Profit216.00M203.00M213.00M173.00M164.00M135.00M
EBITDA100.00M197.00M195.00M114.00M87.00M71.00M
Net Income6.00M102.00M75.00M26.00M24.00M-541.00M
Balance Sheet
Total Assets2.08B2.00B2.35B2.29B2.17B1.25B
Cash, Cash Equivalents and Short-Term Investments168.00M201.00M255.00M217.00M362.00M196.00M
Total Debt549.00M499.00M495.00M363.00M312.00M80.00M
Total Liabilities1.21B1.14B1.21B1.04B1.19B980.00M
Stockholders Equity861.00M859.00M1.14B1.24B977.00M268.00M
Cash Flow
Free Cash Flow-50.00M-63.00M6.00M-147.00M-68.00M-52.00M
Operating Cash Flow-5.00M-7.00M38.00M-116.00M-47.00M-35.00M
Investing Cash Flow-40.00M-39.00M-32.00M-56.00M-20.00M-13.00M
Financing Cash Flow-5.00M-23.00M85.00M43.00M238.00M10.00M

Kodak Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price6.31
Price Trends
50DMA
6.58
Positive
100DMA
6.45
Positive
200DMA
6.43
Positive
Market Momentum
MACD
0.33
Negative
RSI
50.96
Neutral
STOCH
54.24
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KODK, the sentiment is Neutral. The current price of 6.31 is below the 20-day moving average (MA) of 6.87, below the 50-day MA of 6.58, and below the 200-day MA of 6.43, indicating a bullish trend. The MACD of 0.33 indicates Negative momentum. The RSI at 50.96 is Neutral, neither overbought nor oversold. The STOCH value of 54.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for KODK.

Kodak Risk Analysis

Kodak disclosed 45 risk factors in its most recent earnings report. Kodak reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Kodak Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
63
Neutral
$316.34M0.90%71.28%-89.20%
60
Neutral
$540.25M17.7511.44%3.26%-4.96%39.42%
51
Neutral
$284.13M13.6327.91%5.71%-9.23%
49
Neutral
$257.42M13.2439.87%-16.52%
49
Neutral
$712.40M0.58%-0.67%-141.58%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
KODK
Kodak
7.04
2.47
54.05%
ACTG
Acacia Research
3.50
-1.01
-22.39%
CASS
Cass Information Systems
40.90
-2.16
-5.02%
QUAD
Quad/Graphics
5.25
-1.55
-22.79%
SPIR
Spire Global
7.32
-6.27
-46.14%
RHLD
Resolute Holdings Management, Inc.
151.42
125.42
482.38%

Kodak Corporate Events

Eastman Kodak Reports Strong Q3 2025 Financial Performance
Nov 7, 2025

Eastman Kodak Company is a global manufacturer specializing in commercial print and advanced materials & chemicals, known for its extensive patent portfolio and commitment to sustainable solutions. In its third-quarter 2025 financial report, Kodak highlighted significant improvements in gross profit and operational EBITDA, alongside a strategic pension reversion transaction. The company’s consolidated revenues increased by 3% to $269 million, driven by a 15% growth in its Advanced Materials & Chemicals segment, despite a slight decline in print revenues. Gross profit surged by 51%, while operational EBITDA saw a remarkable increase from $1 million to $29 million year-over-year. Kodak’s cash balance rose to $168 million, reflecting improved operational profitability, although it decreased from the previous year’s end due to capital expenditures. Looking ahead, Kodak’s management remains focused on reducing debt and enhancing liquidity, with plans to leverage surplus pension assets to strengthen the balance sheet and drive long-term growth.

Business Operations and Strategy
Kodak Finalizes Annuity Contract with Metropolitan Tower
Neutral
Oct 27, 2025

On October 21, 2025, Eastman Kodak Company completed the purchase of an Annuity Contract and transferred assets from the Kodak Retirement Income Plan to Metropolitan Tower Life Insurance Company, following an agreement signed on October 14, 2025. This transaction is part of Kodak’s strategic financial management efforts, potentially impacting its financial stability and obligations to its retirement plan stakeholders.

The most recent analyst rating on (KODK) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on Kodak stock, see the KODK Stock Forecast page.

Business Operations and Strategy
Kodak Transfers $1.8 Billion Pension Obligations
Neutral
Oct 16, 2025

On January 21, 2025, Kodak‘s Board of Directors approved the termination of the Kodak Retirement Income Plan (KRIP), effective March 31, 2025, ceasing further benefit accruals. By October 14, 2025, Kodak entered into an agreement to transfer approximately $1.8 billion of pension obligations to Metropolitan Tower Life Insurance Company via a nonparticipating single premium group annuity contract. This transaction, expected to close on October 21, 2025, will cover around 27,000 participants, ensuring continued benefit payments until early 2026 when the insurer assumes full responsibility. Additionally, Kodak settled $76 million in pension obligations through lump-sum payments to deferred vested participants on October 1, 2025, and plans to settle $157 million to active participants by November 1, 2025. Any remaining liabilities will be transferred to the Pension Benefit Guaranty Corporation, with surplus assets expected to be distributed by December 2025.

The most recent analyst rating on (KODK) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Kodak stock, see the KODK Stock Forecast page.

Kodak’s Earnings Call: Mixed Results Amid Challenges
Sep 1, 2025

The recent earnings call for Eastman Kodak Company painted a mixed picture, reflecting both positive strides and ongoing challenges. While the company reported growth in its Advanced Materials and Chemicals (AMC) business and advancements in pharmaceutical manufacturing, it also faced declines in key financial metrics such as revenue, gross profit, and net income. Moreover, concerns about Kodak’s ability to continue as a going concern added a layer of uncertainty to the overall sentiment.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 18, 2025